These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29625253)
41. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. Kim CK; Han JH J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318 [TBL] [Abstract][Full Text] [Related]
42. Liposomes for intravenous drug targeting: design and applications. Metselaar JM; Mastrobattista E; Storm G Mini Rev Med Chem; 2002 Aug; 2(4):319-29. PubMed ID: 12370053 [TBL] [Abstract][Full Text] [Related]
43. Assessment of the efficacy of in vivo CFTR protein replacement therapy in CF mice. Ramjeesingh M; Huan LJ; Wilschanski M; Durie P; Li C; Gyomorey K; Wang Y; Kent G; Tanswell KA; Cutz E; Ackerley C; Bear CE Hum Gene Ther; 1998 Mar; 9(4):521-8. PubMed ID: 9525313 [TBL] [Abstract][Full Text] [Related]
44. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer. Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357 [TBL] [Abstract][Full Text] [Related]
45. [Research progress of liposome drug delivery system in stomatology]. Hu ZM; Liu SY; Yang HY; Huang C Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Mar; 56(3):294-300. PubMed ID: 33663162 [TBL] [Abstract][Full Text] [Related]
46. Liposomal Delivery Systems: Design Optimization and Current Applications. Abu Lila AS; Ishida T Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940 [TBL] [Abstract][Full Text] [Related]
47. Cell-free production of VDAC directly into liposomes for integration with biomimetic membrane systems. Liguori L; Stidder B; Alcaraz JP; Lenormand JL; Cinquin P; Martin DK Prep Biochem Biotechnol; 2016 Aug; 46(6):546-51. PubMed ID: 26443900 [TBL] [Abstract][Full Text] [Related]
48. Cell-free compartmentalized protein synthesis inside double emulsion templated liposomes with in vitro synthesized and assembled ribosomes. Caschera F; Lee JW; Ho KK; Liu AP; Jewett MC Chem Commun (Camb); 2016 Apr; 52(31):5467-9. PubMed ID: 27019994 [TBL] [Abstract][Full Text] [Related]
49. Current problems and future avenues in proteoliposome research. Amati AM; Graf S; Deutschmann S; Dolder N; von Ballmoos C Biochem Soc Trans; 2020 Aug; 48(4):1473-1492. PubMed ID: 32830854 [TBL] [Abstract][Full Text] [Related]
50. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180 [TBL] [Abstract][Full Text] [Related]
51. Determinants of liposome fusion mediated by synaptic SNARE proteins. Schuette CG; Hatsuzawa K; Margittai M; Stein A; Riedel D; Küster P; König M; Seidel C; Jahn R Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2858-63. PubMed ID: 14981239 [TBL] [Abstract][Full Text] [Related]
53. Control of the unidirectional topological orientation of a cross-linked complex composed of the bacterial photosynthetic reaction center and horse heart cytochrome c reconstituted into proteoliposomes. Ueno T; Hara M; Kamo N; Fujii T; Miyake J J Biochem; 1998 Sep; 124(3):485-90. PubMed ID: 9722656 [TBL] [Abstract][Full Text] [Related]
54. Formation of artificial multicompartment vesosome and dendrosome as prospected drug and gene delivery carriers. Paleos CM; Tsiourvas D; Sideratou Z; Pantos A J Control Release; 2013 Aug; 170(1):141-52. PubMed ID: 23707326 [TBL] [Abstract][Full Text] [Related]
55. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Zylberberg C; Matosevic S Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899 [TBL] [Abstract][Full Text] [Related]
56. Functional characterization of cell-free expressed K Cortes S; Barette C; Beroud R; De Waard M; Schaack B Protein Expr Purif; 2018 May; 145():94-99. PubMed ID: 29366963 [TBL] [Abstract][Full Text] [Related]
57. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery. Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292 [TBL] [Abstract][Full Text] [Related]
58. Direct integration of cell-free-synthesized connexin-43 into liposomes and hemichannel formation. Moritani Y; Nomura SM; Morita I; Akiyoshi K FEBS J; 2010 Aug; 277(16):3343-52. PubMed ID: 20608976 [TBL] [Abstract][Full Text] [Related]
59. Cell-free translation of integral membrane proteins into unilamelar liposomes. Goren MA; Nozawa A; Makino S; Wrobel RL; Fox BG Methods Enzymol; 2009; 463():647-73. PubMed ID: 19892197 [TBL] [Abstract][Full Text] [Related]